Younger investors are rewriting the rules of wealth building, and five overlooked dividend stocks un

Corient Private Wealth LP trimmed its position in Kenvue Inc. (NYSE: KVUE) by 26.5% during the undef

Johnson & Johnson has raised its dividend for 64 straight years, but faces billions in talc-related

Kimberly-Clark prepares EU concessions to win approval for its $40B Kenvue deal, following Australia

Kenvue's dependable dividend is above average, and it could go even higher if the company is bought

Kimberly-Clark is readying concessions to address ​EU antitrust concerns about ‌its bid for Tylenol

Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a ne

Owning consumer staples stocks is an absolute must in a dividend investing strategy. Most people tur

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors

KVUE's trusted brands, innovation and productivity initiatives support growth as it strengthens its

Kenvue's profit margins and cash flow improved in the first half, but modest sales growth, debt and

KVUE nears its planned combination after shareholder and U.S. antitrust clearances, while margin, de

Australia's competition regulator on Wednesday approved Kimberly-Clark's proposed $40 billion takeov

Kimberly-Clark has asked EU regulators permission ​for its proposed $40 billion takeover ‌of Tylenol

Callan Family Office LLC bought a new position in shares of Kenvue Inc. (NYSE: KVUE) during the unde

AssuredPartners Investment Advisors LLC acquired a new position in shares of Kenvue Inc. (NYSE: KVUE

B and T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Kenvue Inc

Accomplished legal executive and global litigator brings proven track record of enterprise risk mana

KVUE's Q2 sales and earnings miss estimates, but organic growth improved as Skin Health and Beauty l

Kimberly-Clark is rated Buy, supported by a strong innovation pipeline, international growth, and up

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11

Kimberly-Clark remains a compelling value and income play, supported by strong brands and resilient

The Trump administration is reportedly considering an executive order on vaccines and autism as earl

Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc l

TYLENOL® with Naproxen is a clinically proven, opioid-free, fixed-dose combination that begins worki

Barclays analyst Lauren Lieberman maintains Kenvue (NYSE:KVUE) with a Equal-Weight and raises the

Kenvue (NYSE:KVUE) reported quarterly earnings of $0.32 per share which beat the analyst consensus e

Daniel Loeb trims major stake in Kenvue as company advances restructuring and prepares for acquisiti

Kimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leader

Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, se

Kenvue investors approve its sale to Kimberly-Clark. Stock nears 52-week lows ahead of February earn

The $48.7 billion Kimberly-Clark–Kenvue deal could reshape major consumer staples ETFs like XLP, VDC

Wall Street opened the week on a mixed note on Monday.

Buffett Sells Stocks

Wall Street is on track for its third straight day of gains, with major large-cap indices extending

Jim Cramer discussed companies such as Western Union, Johnson Controls, MNTN, Nordic American Tanker

https://www.wsj.com/health/healthcare/rfk-jr-hhs-to-link-autism-to-tylenol-use-in-pregnancy-and

Ten large-cap stocks with worst performance last week. LULU, BF-B, DOCU, TSLA, CIEN, KVUE, KMB, PSO,

Activist investor Dan Loeb's Third Point LLC acquired a significant stake in consumer health com

U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Re

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly e